Study Title
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Study Details
Description:
Patients will be treated with GD2-SADA and 177Lu-DOTA to study the safety and how well participants tolerate the treatment.
Sponsor:
Y-mAbs Therapeutics, Inc.
Government Study Link:
NCT05130255 - Click here to see study onClinicalTrials.gov